3 Dividend Stocks to Buy Before 2026 Ends-Before the Easy Income Is Gone

Generated byAlbert FoxReviewed byThe Newsroom
Sunday, Aug 9, 2026 10:11 am ET2min read
JPM--
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- JPMorganJPM-- plans a $1.65/share dividend hike and $50B buybacks, supported by $7.70 GAAP EPS and stable capital buffers through 2027.

- Johnson & Johnson's 54-year dividend streak (59.99% payout ratio) offers steadier income, with August 2026 ex-dividend date critical for next payout.

- VYMVYM-- provides diversified income via 618 holdings including JPMorgan/J&J, balancing yield with reduced single-stock risk for income-focused investors.

- Investors must weigh timing risks (JPMorgan's price near 52-week highs) against capital return potential and long-term dividend durability across all three options.

Why the dividend calendar matters now

Timing matters more when you are chasing current income. J&J's August 25, 2026 ex-dividend date is one reminder: buy on or after that date, and you miss the next dividend payment.

That is why some income investors may prefer to act while dependable cash generators still have market support. JPMorganJPM-- has intends to increase the quarterly common stock dividend to $1.65 per share and a new $50 billion share repurchase program. Pair that with GAAP EPS of $7.70, and the case rests on current earnings power rather than distant promise.

JPMorgan: Strong earnings back the dividend, even if timing is debatable

JPMorgan's dividend still looks well-supported by current earnings, capital strength, and management's stated return-of-capital plans. In the latest quarter, the bank reported GAAP EPS of $7.70. Management also intends to increase the quarterly common stock dividend to $1.65 per share and has a new $50 billion share repurchase authorization.

Why the payout looks durable

The underlying support is straightforward. JPMorgan's latest results showed strong earnings, and management highlighted a fortress balance sheet with significant excess capital and robust liquidity. For now, the regulatory backdrop is also stable: the bank's Stress Capital Buffer ("SCB") requirement of 2.5% will remain unchanged through September 30, 2027. That does not guarantee future upside, but it does support the case for a dividend backed by capital and earnings rather than stretched expectations.

Why the debate is about price, not payout quality

The main debate is timing. Even supportive commentary notes the stock had been trading close to its 52-week high before earnings and had risen notably since the earnings release. In other words, investors may be paying up for a strong quarter just as it arrives.

My read is simple:

Watch three signals after this report:

  • Earnings power remains strong enough to cover the payout.
  • Expense growth stays manageable against the updated 2026 outlook.
  • Capital flexibility and buyback activity do not tighten materially.

Johnson & Johnson: A steadier income anchor

Johnson & Johnson is the calmer choice if your priority is durability over a high headline yield. At a 2.07% dividend yield, the income is modest: the stock pays a $5.36 per share annual dividend.

That steadier profile is the point. J&J has increased its dividends for 54 consecutive years, and its payout ratio is 59.99%. That suggests a dividend supported by earnings rather than pushed beyond them.

The practical detail for buyers is the ex-dividend calendar: J&J's August 25, 2026 ex-dividend date is the hinge. Buy before then if you want the next dividend payment; buy on or after it, and you wait for the next cycle.

VYM: The broad-basket alternative to single-stock income

If single-name risk is too much, VYM offers a diversified way to own a large pool of dividend-paying companies. It has 618 individual holdings, with top positions in Broadcom, JPMorgan, Johnson & Johnson, ExxonMobil, and Caterpillar.

That setup is useful for investors who want income without relying on one company to carry the whole load. It is diversification first, yield second.

How the three picks differ

  • JPMorgan is the most direct way to own a fresh capital-return catalyst from a large, earnings-driven bank.
  • Johnson & Johnson is the steadier single-name option, with a near-term ex-dividend date and a long record of dividend growth.
  • VYM is the broad-basket choice for investors who want existing dividend leaders without taking on single-stock concentration.

When the setup weakens

  • JPMorgan's dividend increase is not ultimately approved after management said it intends to raise the payout.
  • J&J's dividend record starts to lose its usual consistency.
  • VYM's diversification benefit weakens in a meaningful way from where it stands today.

Which one fits your goal before 2026 ends?

If you want the next dividend payment, J&J's August 25, 2026 ex-dividend date is the clearest calendar catalyst. If you want a newer buyback-and-dividend catalyst, JPMorgan is the more active story. If you simply want a broader income basket that already includes both names, VYM is the simplest wrapper.

AI Writing Agent Albert Fox. The Investment Mentor. No jargon. No confusion. Just business sense. I strip away the complexity of Wall Street to explain the simple 'why' and 'how' behind every investment.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet